Corcept Therapeutics Incorporated Earning Date (CORT)

USA |NASDAQ |USD

CORT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Jul 27, 2022 Jun 2022 $0.26 - $0.21
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Jul 27, 2022 Jun 2022 $102.89M - $91.59M

Corcept Therapeutics Incorporated's next earnings date is Wednesday, Jul 27, 2022 for the fiscal quarter ending Jun 2022.

CORT Earnings Date & History Chart

CORT Earnings & Revenue Forecast

CORT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 4 $0.26 $0.23 $0.34
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $0.97 $0.76 $1.27
Dec 2023 5 $1.22 $0.96 $1.51

CORT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 1 / 0 $0.24 $0.27 $0.24
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 1 / 0 $0.90 $1.00 $0.91
Dec 2023 2 / 0 $1.11 $1.17 $1.05

CORT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 6 $102.89M $101.80M $104.61M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 6 $413.85M $408.00M $421.76M
Dec 2023 6 $458.42M $430.90M $483.40M

CORT Earnings Date & Revenue History

CORT Earnings History

|
Show More
Show More

CORT Revenue History

|
Show More
Show More

Corcept Therapeutics Incorporated Next Earnings Date & Report

CORT Next Earnings Date & Report Preview: Jun 2022 (FQ)

CORT's next earnings date is Wednesday, Jul 27, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Corcept Therapeutics Incorporated's next quarterly earnings is $0.26, with a low EPS estimation of $0.23, and a high estimation of $0.34.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $0.24, the last 2 month trend is $0.27, and the 3 month trend is $0.24.

Based on analysts, the average revenue estimation is $102.89M, with a low revenue estimation of $101.80M, and a high estimation of $104.61M.

Corcept Therapeutics Incorporated Previous Earnings Dates & Reports

CORT Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Corcept Therapeutics Incorporated's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.

CORT Previous Earnings Date & Report Recap: Dec 2021 (FY)

Corcept Therapeutics Incorporated's previous annual earnings date was Feb 15, 2022 for its fiscal year ended Dec 31, 2021.

CORT's earnings per share (EPS) was $0.89, beating the consensus analysts forecast of $0.86 by 3.49% , and higher than the previous year's EPS (Dec 2020) by 4.71%.

Revenues were $365.98M, worse than the forecast of $367.74M by -0.48%, and up by 3.42% from previous year's revenue.

The company reported a net income of $112.51M, 6.13% higher than the previous year.

Corcept Therapeutics Incorporated reported a free cash flow of $167.42M for its fiscal year, compared to $150.73M a year ago.

The company ended the fiscal year with $526.00K in total debt, a decrease of -79.38% compared to the previous year.